Skip to Main Content

Paper Details

A prospective, observational, open-label, multicentre study to investigate the daily treatment practice of ranibizumab in patients with neovascular age-related macular degeneration.
Acta Ophthalmol
28
2015
Author NameAffiliation
Freekje van AstenRadboud University Medical Center
  • 1 - 1

Datasets

Release 1.2